These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 19204151

  • 1. Visualizing the cause of gray matter atrophy in multiple sclerosis.
    Richert ND, Kraft E, Stüve O.
    Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
    [No Abstract] [Full Text] [Related]

  • 2. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 3. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 4. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 5. Is progressive multiple sclerosis a gray matter disease?
    Geurts JJ.
    Ann Neurol; 2008 Sep 15; 64(3):230-2. PubMed ID: 18825672
    [No Abstract] [Full Text] [Related]

  • 6. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 7. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
    Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M.
    Neurology; 2005 Oct 11; 65(7):1126-8. PubMed ID: 16217074
    [Abstract] [Full Text] [Related]

  • 8. Re: Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Gout O.
    Neurology; 2008 Jul 01; 71(1):69; author reply 69. PubMed ID: 18591511
    [No Abstract] [Full Text] [Related]

  • 9. Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
    Banwell BL, Sled JG.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1065-6. PubMed ID: 18362266
    [No Abstract] [Full Text] [Related]

  • 10. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H, Geurts JJ.
    Expert Rev Neurother; 2007 Mar 25; 7(3):271-9. PubMed ID: 17341175
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tourettism in multiple sclerosis: a case report.
    Nociti V, Fasano A, Bentivoglio AR, Frisullo G, Tartaglione T, Tonali PA, Batocchi AP.
    J Neurol Sci; 2009 Dec 15; 287(1-2):288-90. PubMed ID: 19695578
    [Abstract] [Full Text] [Related]

  • 14. What you see depends on how you look: Gray matter lesions in multiple sclerosis.
    Chard DT, Miller DH.
    Neurology; 2009 Sep 22; 73(12):918-9. PubMed ID: 19692676
    [No Abstract] [Full Text] [Related]

  • 15. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
    Filippi M, Rocca MA.
    Adv Neurol; 2006 Sep 22; 98():167-83. PubMed ID: 16400834
    [No Abstract] [Full Text] [Related]

  • 16. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [Abstract] [Full Text] [Related]

  • 17. Rate of brain atrophy in benign vs early multiple sclerosis.
    Gauthier SA, Berger AM, Liptak Z, Duan Y, Egorova S, Buckle GJ, Glanz BI, Khoury SJ, Bakshi R, Weiner HL, Guttmann CR.
    Arch Neurol; 2009 Feb 25; 66(2):234-7. PubMed ID: 19204160
    [Abstract] [Full Text] [Related]

  • 18. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ.
    J Neurol Sci; 2009 Oct 15; 285(1-2):268-9; author reply 269. PubMed ID: 19500803
    [No Abstract] [Full Text] [Related]

  • 19. The diagnosis of MS: white spots and red flags.
    Ratchford JN, Calabresi PA.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1071-2. PubMed ID: 18362269
    [No Abstract] [Full Text] [Related]

  • 20. The Toronto traumatic brain injury study: injury severity and quantified MRI.
    Levine B, Kovacevic N, Nica EI, Cheung G, Gao F, Schwartz ML, Black SE.
    Neurology; 2008 Mar 04; 70(10):771-8. PubMed ID: 18316688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.